PCRX insider transaction filings
Pacira BioSciences, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-18. Screen PCRX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | SLONIN JONATHAN — Chief Medical Officer | Sale (S): 3,040 @ $23.23 | EDGAR |
| 2026-06-12 | 4 | Hirawat Samit — Director | Grant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | RIKER LAUREN — Senior Vice President, Finance | Sale (S): 6,115 @ $23.50 | EDGAR |
| 2026-06-12 | 4 | CHRISTIE CHRISTOPHER — Director | Grant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Young Alethia — Director | Grant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | YANG MICHAEL J. — Director | Grant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | BIGAL MARCELO — Director | Grant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Froimson Mark — Director | Grant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Brege Laura — Director | Grant/award (A): 6,405 @ $0 · Grant/award (A): 10,891 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | WIGGANS THOMAS G — Director | Grant/award (A): 32,675 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | RIKER LAUREN — Senior Vice President, Finance | Tax withholding (F): 3,187 @ $22.32 | EDGAR |
| 2026-06-05 | 4 | SLONIN JONATHAN — Chief Medical Officer | Tax withholding (F): 4,728 @ $22.32 | EDGAR |
| 2026-06-05 | 4 | WILLIAMS KRISTEN — Chief Administrative Officer | Tax withholding (F): 8,528 @ $22.32 · Sale (S): 10,259 @ $22.27 | EDGAR |
| 2026-04-24 | 4 | Cross Shawn — Chief Financial Officer | Option exercise (M): 12,941 @ $16.45 · Sale (S): 12,941 @ $25.16 · Option exercise (M): 12,941 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | Cross Shawn — Chief Financial Officer | Option exercise (M): 7,714 @ $16.45 · Sale (S): 7,714 @ $25.14 · Option exercise (M): 2,845 @ $16.45 · Sale (S): 2,845 @ $25.01 · Option exercise (M): 1,500 @ $16.45 · Sale (S): 1,500 @ $25.01 · +3 more | EDGAR |
| 2026-03-19 | 4 | SLONIN JONATHAN — Chief Medical Officer | Sale (S): 3,261 @ $22.82 | EDGAR |
| 2026-03-19 | 4 | Froimson Mark — Director | Sale (S): 500 @ $21.81 | EDGAR |
| 2026-03-19 | 4/A | Kronenfeld Mark A. — Director | Grant/award (A): 6,163 @ $0 | EDGAR |
| 2026-02-13 | 4 | Cross Shawn — Chief Financial Officer | Grant/award (A): 49,091 @ $0 | EDGAR |
| 2026-02-13 | 4 | Teehan Brendan — Chief Commercial Officer | Grant/award (A): 51,714 @ $0 | EDGAR |
| 2026-02-13 | 4 | RIKER LAUREN — Senior Vice President, Finance | Grant/award (A): 19,273 @ $0 | EDGAR |
| 2026-02-13 | 4 | SLONIN JONATHAN — Chief Medical Officer | Grant/award (A): 54,546 @ $0 | EDGAR |
| 2026-02-13 | 4 | Lee Frank D. — Chief Executive Officer, Director | Grant/award (A): 261,818 @ $0 | EDGAR |
| 2026-02-13 | 4 | WILLIAMS KRISTEN — Chief Administrative Officer | Grant/award (A): 54,546 @ $0 | EDGAR |
| 2026-02-03 | 4 | RIKER LAUREN — Senior Vice President, Finance | Tax withholding (F): 2,751 @ $20.54 · Sale (S): 4,000 @ $20.81 | EDGAR |
| 2026-02-03 | 4 | SLONIN JONATHAN — Chief Medical Officer | Tax withholding (F): 6,168 @ $20.54 | EDGAR |
| 2026-02-03 | 4 | Teehan Brendan — Chief Commercial Officer | Tax withholding (F): 5,182 @ $20.54 | EDGAR |
| 2026-02-03 | 4 | Lee Frank D. — Chief Executive Officer, Director | Tax withholding (F): 41,488 @ $20.54 | EDGAR |
| 2026-02-03 | 4 | WILLIAMS KRISTEN — Chief Administrative Officer | Tax withholding (F): 17,134 @ $20.54 · Sale (S): 13,137 @ $20.53 | EDGAR |
| 2026-01-29 | 4 | Hirawat Samit — Director | Grant/award (A): 39,291 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | SLONIN JONATHAN — Chief Medical Officer | Tax withholding (F): 381 @ $24.46 | EDGAR |
| 2026-01-06 | 4 | RIKER LAUREN — Senior Vice President, Finance | Tax withholding (F): 159 @ $24.46 · Sale (S): 1,416 @ $24.24 | EDGAR |
| 2026-01-06 | 4 | Lee Frank D. — Chief Executive Officer, Director | Tax withholding (F): 9,272 @ $24.46 | EDGAR |
| 2026-01-06 | 4 | Teehan Brendan — Chief Commercial Officer | Grant/award (A): 402.27 @ $10.76 | EDGAR |
| 2025-12-11 | 4 | Cross Shawn — Chief Financial Officer | Option exercise (M): 15,896 @ $16.45 · Sale (S): 15,896 @ $25.03 · Option exercise (M): 9,104 @ $16.45 · Sale (S): 9,104 @ $25.14 · Option exercise (M): 15,896 (derivative) @ $0 · Option exercise (M): 9,104 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | SLONIN JONATHAN — Chief Medical Officer | Sale (S): 3,960 @ $24.09 | EDGAR |
| 2025-11-13 | 4 | Cross Shawn — Chief Financial Officer | Sale (S): 12,060 @ $22.09 | EDGAR |
| 2025-11-03 | 4 | Cross Shawn — Chief Financial Officer | Tax withholding (F): 6,690 @ $21.38 | EDGAR |
| 2025-09-08 | 4 | Ceesay Abraham — Director | Sale (S): 2,354 @ $27.19 | EDGAR |
| 2025-08-11 | 4 | BIGAL MARCELO — Director | Sale (S): 4,912 @ $23.67 | EDGAR |
| 2025-08-04 | 4 | SLONIN JONATHAN — Chief Medical Officer | Tax withholding (F): 315 @ $22.07 | EDGAR |
| 2025-06-13 | 4 | Kronenfeld Mark A. — Director | Grant/award (A): 9,999 @ $0 · Grant/award (A): 11,279 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Ceesay Abraham — Director | Grant/award (A): 6,163 @ $0 · Grant/award (A): 11,279 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Froimson Mark — Director | Grant/award (A): 6,163 @ $0 · Grant/award (A): 11,279 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | BIGAL MARCELO — Director | Grant/award (A): 6,163 @ $0 · Grant/award (A): 11,279 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | YANG MICHAEL J. — Director | Grant/award (A): 6,163 @ $0 · Grant/award (A): 11,279 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | CHRISTIE CHRISTOPHER — Director | Grant/award (A): 6,163 @ $0 · Grant/award (A): 11,279 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Young Alethia — Director | Grant/award (A): 6,163 @ $0 · Grant/award (A): 11,279 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Brege Laura — Director | Grant/award (A): 6,163 @ $0 · Grant/award (A): 11,279 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | RIKER LAUREN — Senior Vice President, Finance | Tax withholding (F): 3,374 @ $26.40 · Sale (S): 5,578.34 @ $26.21 | EDGAR |
Recent 8-K events — Pacira BioSciences, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-28 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-08 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-10 | 8-K | ? 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PCRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →